Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

• Author(s): Hegg, Roberto
• Date: 2019
• Origin: Oasisbr
• Subject(s): ANTINEOPLÁSICOS
• Document Type: Journal article
• Language: English